Ovoca Bio (OVB) Competitors GBX 1.85 +0.15 (+8.82%) (As of 11/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitors OVB vs. APTA, IXI, FAB, OBD, BSFA, EVG, MTFB, DEST, TCF, and VALShould you be buying Ovoca Bio stock or one of its competitors? The main competitors of Ovoca Bio include Aptamer Group (APTA), IXICO (IXI), Fusion Antibodies (FAB), Oxford BioDynamics (OBD), BSF Enterprise (BSFA), Evgen Pharma (EVG), Motif Bio (MTFB), Destiny Pharma (DEST), Theracryf (TCF), and ValiRx (VAL). These companies are all part of the "biotechnology" industry. Ovoca Bio vs. Aptamer Group IXICO Fusion Antibodies Oxford BioDynamics BSF Enterprise Evgen Pharma Motif Bio Destiny Pharma Theracryf ValiRx Ovoca Bio (LON:OVB) and Aptamer Group (LON:APTA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, community ranking, risk, analyst recommendations, media sentiment, dividends, profitability, valuation and earnings. Does the media refer more to OVB or APTA? In the previous week, Ovoca Bio's average media sentiment score of 0.00 equaled Aptamer Group'saverage media sentiment score. Company Overall Sentiment Ovoca Bio Neutral Aptamer Group Neutral Does the MarketBeat Community prefer OVB or APTA? Ovoca Bio received 17 more outperform votes than Aptamer Group when rated by MarketBeat users. CompanyUnderperformOutperformOvoca BioOutperform Votes1770.83% Underperform Votes729.17% Aptamer GroupN/AN/A Which has more risk and volatility, OVB or APTA? Ovoca Bio has a beta of 0.9, suggesting that its share price is 10% less volatile than the S&P 500. Comparatively, Aptamer Group has a beta of -0.52, suggesting that its share price is 152% less volatile than the S&P 500. Which has higher earnings and valuation, OVB or APTA? Ovoca Bio has higher earnings, but lower revenue than Aptamer Group. Ovoca Bio is trading at a lower price-to-earnings ratio than Aptamer Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOvoca BioN/AN/A-£3.98M-£0.04-46.25Aptamer Group£1.03M4.10-£7.01M-£0.08-2.75 Is OVB or APTA more profitable? Ovoca Bio's return on equity of -108.96% beat Aptamer Group's return on equity.Company Net Margins Return on Equity Return on Assets Ovoca BioN/A -108.96% 3.70% Aptamer Group N/A -187.53%-44.96% Do analysts prefer OVB or APTA? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ovoca Bio 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AAptamer Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Do institutionals & insiders have more ownership in OVB or APTA? 11.7% of Aptamer Group shares are owned by institutional investors. 44.7% of Ovoca Bio shares are owned by company insiders. Comparatively, 13.2% of Aptamer Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. SummaryOvoca Bio beats Aptamer Group on 7 of the 10 factors compared between the two stocks. Ad Paradigm PressEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.Click here to see it because it’s a SHOCKER… Get Ovoca Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for OVB and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OVB vs. The Competition Export to ExcelMetricOvoca BioBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£1.51M£207.11M£5.06B£1.40BDividend Yield0.83%3.48%7.52%11.77%P/E Ratio-46.25338.28131.961,584.23Price / SalesN/A21,580.151,683.82214,277.95Price / Cash1.0011.2837.1526.96Price / Book0.937.104.612.88Net Income-£3.98M-£19.48M£115.40M£155.21M7 Day Performance15.63%-0.44%-0.26%0.54%1 Month Performance94.33%2.00%5.74%-0.39%1 Year Performance37.04%23.59%33.81%103.11% Ovoca Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OVBOvoca BioN/AGBX 1.85+8.8%N/A+41.0%£1.51MN/A-46.255Gap UpAPTAAptamer GroupN/AGBX 0.24+6.7%N/A-81.9%£4.61M£1.03M-3.0037Positive NewsGap UpIXIIXICON/AGBX 9.25flatN/A-32.1%£4.47M£6M-231.2589FABFusion AntibodiesN/AGBX 4.30+1.2%N/A-14.3%£4.10M£1.14M-107.5048OBDOxford BioDynamicsN/AGBX 1.20-3.2%N/A-96.5%£3.73M£176,000.00-19.9245BSFABSF EnterpriseN/AGBX 3.51-6.4%N/A-57.6%£3.63MN/A-175.5012Gap DownEVGEvgen PharmaN/AN/AN/AN/A£3.42MN/A-80.0010MTFBMotif BioN/AGBX 0.50flatN/AN/A£3.28MN/A-0.036DESTDestiny PharmaN/AGBX 3-30.1%N/AN/A£2.87M£135,028.00-50.0024Gap DownHigh Trading VolumeTCFTheracryfN/AGBX 0.63flatN/AN/A£2.67MN/A-62.5010High Trading VolumeVALValiRxN/AGBX 1.60flatN/A-88.4%£2.12MN/A-80.005,450Gap Down Related Companies and Tools Related Companies APTA Alternatives IXI Alternatives FAB Alternatives OBD Alternatives BSFA Alternatives EVG Alternatives MTFB Alternatives DEST Alternatives TCF Alternatives VAL Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:OVB) was last updated on 11/4/2024 by MarketBeat.com Staff From Our Partners2 sentences that change everything you THOUGHT you knew about tradingIf you're like most people, on Friday morning you'll probably follow your set routine: Wake up... eat breakfas...Investing Daily | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ovoca Bio plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Ovoca Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OVB Stock Alerts